Vincerx Pharma Stock Today
| VINC Stock | USD 0.93 0.04 4.49% |
Performance6 of 100
| Odds Of DistressOver 74
|
Vincerx Pharma is trading at 0.93 as of the 2nd of May 2024, a 4.49 percent up since the beginning of the trading day. The stock's open price was 0.89. Vincerx Pharma has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Vincerx Pharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of March 2024 and ending today, the 2nd of May 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 27th of May 2020 | Category Healthcare | Classification Health Care |
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Vincerx Pharma, Inc. was founded in 2019 is headquartered in Palo Alto, California. The company has 23.53 M outstanding shares of which 1.2 M shares are at this time shorted by private and institutional investors with about 0.72 trading days to cover. More on Vincerx Pharma
Moving together with Vincerx Stock
| 0.82 | BMY | Bristol Myers Squibb Earnings Call This Week | PairCorr |
| 0.63 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
Moving against Vincerx Stock
| 0.57 | JAGX | Jaguar Animal Health Financial Report 20th of May 2024 | PairCorr |
| 0.48 | OVID | Ovid Therapeutics Financial Report 3rd of May 2024 | PairCorr |
| 0.44 | ELYM | Eliem Therapeutics Trending | PairCorr |
Follow Valuation Profit Patterns Odds of Bankruptcy
Financial Report 9th of May 2024
Vincerx Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Vincerx Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Vincerx Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman CoFounder | Ahmed MD | |||||||||||||||||||||||||||||||||||
| Thematic Idea | Pharmaceutical Products (View all Themes) | |||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Vincerx Pharma report their recommendations after researching Vincerx Pharma's financial statements, talking to executives and customers, or listening in on Vincerx Pharma's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Vincerx Pharma. The Vincerx consensus assessment is calculated by taking the average forecast from all of the analysts covering Vincerx Pharma. | ||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Vincerx Pharma's financial statements, Vincerx Pharma is not in a good financial situation at this time. It has a very high odds of going through financial crisis in June. Financial strength of Vincerx Pharma is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||
Vincerx Pharma's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Vincerx Pharma's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Vincerx Pharma's financial leverage. It provides some insight into what part of Vincerx Pharma's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||
Vincerx Pharma (VINC) is traded on NASDAQ Exchange in USA. It is located in 260 Sheridan Avenue, Palo Alto, CA, United States, 94306 and employs 42 people. Vincerx Pharma is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 26.26 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Vincerx Pharma's market, we take the total number of its shares issued and multiply it by Vincerx Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Vincerx Pharma conducts business under Biotechnology sector and is part of Health Care industry. The entity has 23.53 M outstanding shares of which 1.2 M shares are at this time shorted by private and institutional investors with about 0.72 trading days to cover.
Vincerx Pharma currently holds about 80.86 M in cash with (40.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.82, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Vincerx Pharma Probability Of Bankruptcy
Ownership AllocationVincerx Pharma maintains a total of 23.53 Million outstanding shares. 30% of Vincerx Pharma outstanding shares are owned by institutional holders. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Vincerx Ownership Details
Vincerx Stock Price Odds Analysis
What are Vincerx Pharma's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Vincerx Pharma jumping above the current price in 90 days from now is about 84.84%. The Vincerx Pharma probability density function shows the probability of Vincerx Pharma stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 2.1127. This entails as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Vincerx Pharma will likely underperform. Moreover, vincerx Pharma has an alpha of 1.3861, implying that it can generate a 1.39 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Vincerx Pharma to move above the current price in 90 days from now is about 84.84 (This Vincerx Pharma probability density function shows the probability of Vincerx Stock to fall within a particular range of prices over 90 days) .
Vincerx Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Vincerx Pharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vincerx Pharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vincerx Pharma's value.| Instituion | Recorded On | Shares | |
| Renaissance Technologies Corp | 2023-12-31 | 176 K | |
| Citadel Advisors Llc | 2023-09-30 | 168.8 K | |
| Geode Capital Management, Llc | 2023-12-31 | 154 K | |
| Walleye Trading Advisors, Llc | 2023-12-31 | 115 K | |
| Schonfeld Strategic Advisors Llc | 2023-09-30 | 114 K | |
| Sio Capital Management, Llc | 2023-12-31 | 102 K | |
| Blackrock Inc | 2023-12-31 | 64.3 K | |
| State Street Corporation | 2023-12-31 | 43.1 K | |
| Acadian Asset Management Llc | 2023-12-31 | 41.8 K | |
| Goldman Sachs Group Inc | 2023-12-31 | 3.4 M | |
| Sage Rhino Capital Llc | 2023-12-31 | 1.7 M |
Vincerx Pharma Historical Income Statement
Vincerx Pharma Income Statement is one of the three primary financial statements used for reporting Vincerx's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Vincerx Pharma revenue and expense. Vincerx Pharma Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Vincerx Pharma's Net Interest Income is projected to increase significantly based on the last few years of reporting. The current year's Research Development is expected to grow to about 35 M, whereas Interest Expense is projected to grow to (7 M). View More FundamentalsVincerx Stock Against Markets
Picking the right benchmark for Vincerx Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Vincerx Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Vincerx Pharma is critical whether you are bullish or bearish towards Vincerx Pharma at a given time. Please also check how Vincerx Pharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vincerx Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Optimization Now
Portfolio OptimizationCompute new portfolio that will generate highest expected return given your specified tolerance for risk |
| All Next | Launch Module |
Vincerx Pharma Corporate Management
Elected by the shareholders, the Vincerx Pharma's board of directors comprises two types of representatives: Vincerx Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vincerx. The board's role is to monitor Vincerx Pharma's management team and ensure that shareholders' interests are well served. Vincerx Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vincerx Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Melissa SPHR | Director Culture | Profile | |
| Karen Quarford | Vice Compliance | Profile | |
| John MD | Founder Board | Profile | |
| Beatrix StelteLudwig | Executive Officer | Profile |
How to buy Vincerx Stock?
Before investing in Vincerx Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Vincerx Pharma. To buy Vincerx Pharma stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Vincerx Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Vincerx Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Vincerx Pharma stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Vincerx Pharma stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Vincerx Pharma, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Vincerx Stock please use our How to Invest in Vincerx Pharma guide.
Already Invested in Vincerx Pharma?
The danger of trading Vincerx Pharma is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Vincerx Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Vincerx Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Vincerx Pharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Vincerx Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vincerx Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vincerx Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vincerx Pharma Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vincerx Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Vincerx Stock analysis
When running Vincerx Pharma's price analysis, check to measure Vincerx Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vincerx Pharma is operating at the current time. Most of Vincerx Pharma's value examination focuses on studying past and present price action to predict the probability of Vincerx Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vincerx Pharma's price. Additionally, you may evaluate how the addition of Vincerx Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |
Is Vincerx Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vincerx Pharma. If investors know Vincerx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vincerx Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.89) | Return On Assets (0.69) | Return On Equity (1.36) |
The market value of Vincerx Pharma is measured differently than its book value, which is the value of Vincerx that is recorded on the company's balance sheet. Investors also form their own opinion of Vincerx Pharma's value that differs from its market value or its book value, called intrinsic value, which is Vincerx Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vincerx Pharma's market value can be influenced by many factors that don't directly affect Vincerx Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vincerx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vincerx Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vincerx Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.